Articles liés à Comparative Assessment of QOL and Cognitive Function...

Comparative Assessment of QOL and Cognitive Function in Diabetic Drugs: Comparative Assessment of QOL and Cognitive Function - Couverture souple

 
9783659231087: Comparative Assessment of QOL and Cognitive Function in Diabetic Drugs: Comparative Assessment of QOL and Cognitive Function

Synopsis

Diabetes mellitus has become a major cause of illness and disability across the world. The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalence of diabetes and the number of people affected by diabetes now and in the future is important to allow rational planning and allocation of resources. Epidemiological data for India indicates that people affected by diabetes in India presently are about 31,196,000 and projections for 2030 in India are about 79,441,000 as reported in the World Health Organization [WHO] Global Burden of Disease Study. The present work discusses the importance of the antidiabetic therapies in altering the Quality of Life and cognitive parameters in diabetic conditions. The outcome of the study will measure the efficacy of antidiabetic drug on quality of life and cognitive function of the diabetic patients. The comparative efficacy of the antidiabetic drugs used in the treatment of diabetic patients in relation to Sociodemographic and lifestyle characteristics on their Quality of Life and cognitive paradigms will also be revealed.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Diabetes mellitus has become a major cause of illness and disability across the world. The number of people with diabetes is increasing due to population growth, aging, urbanization, and increasing prevalence of obesity and physical inactivity. Quantifying the prevalence of diabetes and the number of people affected by diabetes now and in the future is important to allow rational planning and allocation of resources. Epidemiological data for India indicates that people affected by diabetes in India presently are about 31,196,000 and projections for 2030 in India are about 79,441,000 as reported in the World Health Organization [WHO] Global Burden of Disease Study. The present work discusses the importance of the antidiabetic therapies in altering the Quality of Life and cognitive parameters in diabetic conditions. The outcome of the study will measure the efficacy of antidiabetic drug on quality of life and cognitive function of the diabetic patients. The comparative efficacy of the antidiabetic drugs used in the treatment of diabetic patients in relation to Sociodemographic and lifestyle characteristics on their Quality of Life and cognitive paradigms will also be revealed.

Biographie de l'auteur

Arul Prakasam K.C.M.Pharm., Department of pharmacy practice,JSS College of Pharmacy,OOTY,Tamil Nadu, India

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

  • ÉditeurLAP LAMBERT Academic Publishing
  • Date d'édition2012
  • ISBN 10 3659231088
  • ISBN 13 9783659231087
  • ReliureBroché
  • Langueanglais
  • Nombre de pages76
  • Coordonnées du fabricantnon disponible

Acheter neuf

Afficher cet article
EUR 41,67

Autre devise

EUR 9,70 expédition depuis Allemagne vers France

Destinations, frais et délais

Résultats de recherche pour Comparative Assessment of QOL and Cognitive Function...

Image fournie par le vendeur

Arulprakasam K.C.|P.R. Anand Vijayakumar
ISBN 10 : 3659231088 ISBN 13 : 9783659231087
Neuf Couverture souple
impression à la demande

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: K.C. ArulprakasamArul Prakasam K.C.M.Pharm., Department of pharmacy practice,JSS College of Pharmacy,OOTY,Tamil Nadu, IndiaDiabetes mellitus has become a major cause of illness and disability across the world. The number of peop. N° de réf. du vendeur 5141572

Contacter le vendeur

Acheter neuf

EUR 41,67
Autre devise
Frais de port : EUR 9,70
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier